Fork Township, PA, United States of America

Thomas Oligino

This inventor holds 1 USPTO granted patent. Top assignee: Sanofi-Aventis. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Oligino. Retrieved from https://idiyas.com/inventor/thomas-oligino-rkpeooqa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thomas Oligino: Innovator in Humanized Anti-CXCR5 Antibodies

Introduction

Thomas Oligino is a notable inventor based in Fork Township, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. His work has implications for various therapeutic applications.

Latest Patents

Oligino holds a patent for "Humanized Anti-CXCR5 Antibodies, Derivatives Thereof and Their Uses." This patent represents a critical advancement in the understanding and treatment of diseases related to the CXCR5 receptor.

Career Highlights

Oligino is currently employed at Sanofi-Aventis, a leading global biopharmaceutical company. His role involves research and development, focusing on innovative solutions in the healthcare sector. With 1 patent to his name, he has established himself as a key player in his field.

Collaborations

Throughout his career, Oligino has collaborated with talented professionals, including Renata Lee and Vincent Mikol. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Thomas Oligino's contributions to the field of biotechnology, particularly through his patent on humanized antibodies, highlight his role as an influential inventor. His work continues to impact the development of new therapeutic strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…